Subunit peptide cancer vaccines targeting activating mutations of the p21 ras proto-oncogene.

Triozzi, P L; Stoner, G D; Kaumaya, P T

Triozzi, P L; Stoner, G D; Kaumaya, P T.

Affiliation

Triozzi PL; Division of Hematology/Oncology, Ohio State University Medical Center, Columbus, USA.

Biomed Pept Proteins Nucleic Acids ; 1(3): 185-92, 1995.

Article in En | MEDLINE | ID: mdl-9346851

Subject(s)

Cancer Vaccines/immunology; Epitopes, T-Lymphocyte/immunology; Genes, ras/genetics; Lung Neoplasms/immunology; Mutation; Oncogene Protein p21(ras)/immunology; Peptides/immunology; Amino Acid Sequence; Animals; Cancer Vaccines/chemistry; Cancer Vaccines/genetics; Disease Models, Animal; Dose-Response Relationship, Drug; Epitopes, T-Lymphocyte/chemistry; Epitopes, T-Lymphocyte/genetics; Humans; Lung Neoplasms/genetics; Lung Neoplasms/pathology; Mice; Mice, Inbred BALB C; Oncogene Protein p21(ras)/chemistry; Oncogene Protein p21(ras)/genetics; Peptides/chemistry; Peptides/genetics; Proto-Oncogene Mas

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Oncogene Protein p21(ras) / Genes, ras / Epitopes, T-Lymphocyte / Cancer Vaccines / Lung Neoplasms / Mutation Limits: Animals / Humans Language: En Journal: Biomed Pept Proteins Nucleic Acids Journal subject: BIOQUIMICA Year: 1995 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links